Soleno Therapeutics (SLNO) Gross Profit (QoQ) (2015 - 2026)

Soleno Therapeutics (SLNO) Gross Profit (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.85 Bn 467.06 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.28 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.47 Bn 959.66 Mn
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.79%
Dec 31, 2025 40.06%
Sep 30, 2025 102.99%
Sep 30, 2018 -84.62%
Jun 30, 2017 -173.21%
Mar 31, 2017 -8.92%
Dec 31, 2016 187.83%
Sep 30, 2016 -42.86%
Jun 30, 2016 -250.00%
Mar 31, 2016 7.96%
Dec 31, 2015 -107.96%
Sep 30, 2015 154.67%
Jun 30, 2015 1,775.00%